Sponsored Ad | NIKKEI FORUM MELBOURNE 2025 - Leaderboard

China’s Chime Biologics nets $190m funding led by VMS Group

China’s Chime Biologics nets $190m funding led by VMS Group

Source: National Cancer Institute/Unsplash

27 March, 2021

Chime Biologics (Wuhan)VMS Group

Printed by Unregistered user on Mon, 04 Aug 2025 05:24:49 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Panacea Venture hits final close of oversubscribed healthcare fund at $180.5m

Venture Capital

IDG, Qiming co-lead $70m Series B funding in biotech firm ZhenGe

Read more from Greater China

China Deal Review: Dealmaking holds up in July amid signs of market recovery

China’s solar giants quietly shed a third of their workforces last year